Roche
See the following -
3 Reasons Why Pharma mHealth Apps Have Failed
Pharma mHealth companies are struggling to have an impact on the mHealth app market generating only limited downloads and usage, despite releasing more than 100 pharma mHealth apps for iOS and Android...
- Login to post comments
Across Pharma, Few Open Arms For Trial Data Sharing
Industry inches toward consensus on limited sharing as EMA, GSK press for open access. Read More »
- Login to post comments
Big Pharma Plays Hide-The-Ball With Data
...[E]vidence released earlier this year by Cochrane Collaboration, a London-based nonprofit, shows that a significant amount of negative data from [Tamiflu's] clinical trials were hidden from the public. The Food and Drug Administration (FDA) knew about it, but the medical community did not; the U.S. Centers for Disease Control and Prevention (CDC), which doesn’t have the same access to unpublished data as regulators, had recommended the drug without being able to see the full picture...
- Login to post comments
Drugs Companies Buy NHS Patient Data, Register Reveals
Some of world's biggest pharmaceutical companies have bought NHS patient data, a new register has revealed. Drugs corporations including Bayer, Baxter, AstraZeneca and Roche are among dozens of private firms sold information, as well as Bupa, the healthcare provider.
- Login to post comments
European Bioinformatics Institute (EMBL-EBI) ChEMBL 20 incorporates the Pistoia Alliance’s HELM annotation
The European Bioinformatics Institute (EMBL-EBI) has released version 20 of ChEMBL, the database of compound bioactivity data and drug targets. ChEMBL now incorporates the Hierarchical Editing Language for Macromolecules (HELM), the macromolecular representation standard recently released by the Pistoia Alliance.
- Login to post comments
Expensive Drugs Forcing Cancer Doctors To Weigh Price
...With new cancer drugs priced as high as $10,000 a month and more, and insurers tightening payment rules, patients who thought they were well covered increasingly find themselves having to make life-altering decisions about what they can afford.
- Login to post comments
J&J, Roche And Others Back Tech Platform To Bolster Translational Drug Research
Pharma experts and academics have joined forces to support an existing platform for managing digital translational research data, and their efforts could boost the plodding pace of drug research. The tranSMART Foundation incorporated as a nonprofit last week to organize the open source effort, Roche's ($RHHBY) Michael Braxenthaler, who serves as co-CEO of the foundation, told FierceBiotech IT. Read More »
- Login to post comments
Life Science and IT Organizations Invest in the tranSMART Foundation to Advance Translational Medicine Research
The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced that 20 life sciences and technology organizations have made substantial commitments by joining its Membership Program. Read More »
- Login to post comments
More Data, Better Drugs: Genetech, PatientsLikeMe Ink Groundbreaking Research Pact
Genentech Inc. will mine the deep online patient network of PatientsLikeMe to pinpoint ways of using patients' real experience with diseases and drugs for better research. The five-year agreement is the first broad research collaboration between Cambridge, Mass.-based PatientsLikeMe and a drug company, but it also demonstrates how open-source research and social media are increasingly tapped by companies to get real-world insights into diseases and how patients respond to treatments.
- Login to post comments
Pfizer Shares Software For Biotech Drug Research With Pharma Rivals
Pfizer ($PFE) has led the way in an effort to share software and standards for managing data on complex molecules, providing the tech know-how on a precompetitive basis to competitors such as GlaxoSmithKline ($GSK), Roche ($RHHBY) and Bristol-Myers Squibb ($BMY). Read More »
- Login to post comments
Red Hat Innovation Award Finalists in the Healthcare Arena
Red Hat, the world's leading provider of open source solutions, recently announced the finalists of the seventh annual Red Hat Innovation Awards. The awards program recognizes customers, partners and communities for their outstanding use, innovation, and extension of Red Hat technology. The following are three of the finalists in the healthcare arena. Read More »
- Login to post comments
Red Hat Recognizes Cutting-Edge Open Source Deployments In Seventh Annual Innovation Awards
Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, today announced the finalists of the seventh annual Red Hat Innovation Awards. The awards program recognizes customers, partners and communities for their outstanding use, innovation, and extension of Red Hat technology. Read More »
- Login to post comments
The tranSMART Foundation Announces New Version of the tranSMART Open Source Data Sharing Platform for the Life Sciences Community
The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share their pre-competitive data, today announced the release of tranSMART version 1.1.
- Login to post comments
U.K. Health Service Sold Patient Data To Drug Companies
Some of the world's leading pharmaceutical companies have purchased patient data from the United Kingdom's National Health Service, according to a new registry, the London Telegraph reports. The registry comes shortly after the Telegraph reported that the NHS Information Centre improperly sold hospital data covering 47 million patients over 13 years to the insurance industry.
- Login to post comments
UNESCO Partners With Nature Education And Roche To Launch The World Library Of Science: A Free Online Science Education Resource
UNESCO launched the UNESCO World Library of Science (WLoS), a newly created, free online science education resource for a global community of users. Developed through the joint efforts of UNESCO, Nature Education and Roche, the WLoS was created to give students around the world, especially those in disadvantaged regions, access to the latest science information as well as the opportunity to share their experiences and learning through discussion with their peers in a shared learning environment... Read More »
- Login to post comments